Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Bristol-Myers Squibb Co. (NYSE:BMY)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Bristol-Myers Squibb Co. for $17.99, or

  • get full access to the entire website for at least 3 months from $49.99.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Bristol-Myers Squibb Co. pages available today for free:

Common-Size Income Statement

Beginner level

Bristol-Myers Squibb Co., common-size consolidated income statement

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net product sales
Alliance and other revenues
Revenues
Cost of products sold, excludes amortization of acquired intangible assets
Gross margin
Marketing, selling and administrative
Research and development
Amortization of acquired intangible assets
Operating income
Interest expense
Pension and postretirement
Royalties and licensing income
Divestiture gains
Acquisition expenses
Contingent value rights
Investment income
Integration expenses
Provision for restructuring
Equity investment gains (losses)
Litigation and other settlements
Transition and other service fees
Intangible asset impairment
Equity in net income (loss) of affiliates
Loss on debt redemption
Written option adjustment
Other
Other income (expense), net
Earnings before income taxes
Provision for income taxes
Net earnings
Noncontrolling interest
Net earnings attributable to BMS

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

Income statement item Description The company
Operating income The net result for the period of deducting operating expenses from operating revenues. Bristol-Myers Squibb Co.’s operating income as a percentage of revenues increased from 2017 to 2018 but then slightly decreased from 2018 to 2019.
Earnings before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Bristol-Myers Squibb Co.’s earnings before income taxes as a percentage of revenues increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.
Net earnings attributable to BMS The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Bristol-Myers Squibb Co.’s net earnings attributable to BMS as a percentage of revenues increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.